Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma | Chua H.-H.; Tsuei D.-J.; PO-HUANG LEE ; YUNG-MING JENG ; Lu J.; JIA-FENG WU ; Su D.-S.; Chen Y.-H.; Chien C.-S.; Kao P.-C.; CHIEN-NAN LEE ; REY-HENG HU ; YEN-HSUAN NI ; MEI-HWEI CHANG | Hepatology | 56 | 51 |